New research indicates that a drug commonly prescribed for gout may also lower the risk of heart attack and stroke when taken at an appropriate dose. Researchers from the UK, Sweden and Italy analyzed ...

Colchicine use was linked to a 12% reduction in the risk for total joint arthroplasty among patients with gout. Colchicine use is associated with a modest reduction in the long-term risk for total ...

Medications taken to treat gout can help people with that condition reduce their risk of heart attack and stroke. That’s the conclusion of a new research analysis recently published in JAMA Internal ...

A groundbreaking new study, led by experts at the University of Nottingham, has found that medicines used to treat gout can also reduce the risk of heart attack and stroke in people with gout. The new ...

Gout is becoming a younger man’s disease. Gout medications like allopurinol reduce heart attack and stroke risks, new study finds. “This is the first study to find that medicines such as allopurinol..

A new study, led by experts at the University of Nottingham, has found that medicines used to treat gout can also reduce the risk of heart attack and stroke in people with gout. The new research, ...

A new study finds that TikTok videos about gout frequently spread confusing or inaccurate advice. Most clips focus on diet changes and supplements, while barely mentioning the long-term treatments ...

Cases of gout are rising in younger individuals, according to a global study. The condition, which is a type of inflammatory arthritis, steadily increased in people aged 15 to 39 between 1990 and 2021 ...

Gout, the most common form of inflammatory arthritis, often coexists with comorbidities that require integrated assessment and treatment. The burden of cardiovascular-kidney-metabolic (CKM) ...

For $950 million upfront, Sobi will gain ownership to pozdeutinurad, an oral URAT1 inhibitor that performed well in Phase II studies. Sobi is taking over California-based Arthrosi Therapeutics in a ...

Osteoporosis may be under-recognized and inadequately managed in gout patients, new research presented at the American College of Rheumatology (ACR) annual meeting suggested. Compared with ...